HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Urethral cancer is a rare form of cancer that originates in the urethra, the tube responsible for carrying urine from the bladder to the external body. This type of cancer accounts for a small percentage of all urological cancers. Urethral cancer is more prevalent in women than in men, with the majority of cases affecting the elderly. The exact cause of urethral cancer remains unclear, but certain risk factors may contribute to its development. These include a history of chronic inflammation, recurrent urinary tract infections, and exposure to certain chemicals. Additionally, the presence of human papillomavirus (HPV) has been linked to an increased risk of developing urethral cancer. Symptoms of urethral cancer may include blood in the urine, painful urination, and an abnormal discharge. As the disease progresses, individuals may experience pelvic pain and notice changes in urinary habits. Early diagnosis is crucial for effective treatment, which may involve a combination of surgery, radiation therapy, and chemotherapy. Prognosis for urethral cancer depends on various factors, including the stage at which it is diagnosed and the overall health of the patient. As with many cancers, early detection and intervention significantly improve the chances of successful treatment. Regular medical check-ups and prompt evaluation of any concerning symptoms can aid in the timely diagnosis and management of urethral cancer.
